The health and wellness of ourselves and our community depend on clear, fast, and actionable information on the health threats we face as a community. Luxor Scientific offers an extensive testing menu to best serve the healthcare community and is committed to doing its’ part to help inform and prepare the populace to deal with communal threats like the Flu, Monkey Pox, or COVID-19. Dedicated scientists are available to answer questions.
Infectious Disease
Detect Infection First.
- Respiratory / ENT Pathogens
- SARS-CoV-2
- Sexually Transmitted Infection (STI)
- Urinary Tract Infection (UTI)
- Wound Infection
- Fungal Infection
- Monkey Pox
- Antibiotics (ABX) Resistance Markers
- Tick-Borne Illnesses
Our extensive menu ensures providers have the most comprehensive information when making treatment decisions.
- Streptococcus pyogenes (Strep A)
- SARS-CoV-2
- Influenza Pathogens
- Influenza A virus (Pan)
- Influenza A virus H1-2009
- Influenza A virus H3
- Influenza B virus
- Respiratory Syncytial Virus
- Respiratory Syncytial Virus A
- Respiratory Syncytial Virus B
- Common Cold Pathogens
- Adenovirus 1 & 2 Alpha
- Coronavirus HKU1
- Coronavirus NL63
- Coronavirus OC43
- Coronavirus 229E
- Human Rhinovirus 1 and 2
- Parainfluenza Panel
- Parainfluenza 1
- Parainfluenza 2
- Parainfluenza 3
- Parainfluenza 4
- Bacterial Pathogens
- Bordetella (PAN)
- Bordetella pertussis
- Chlamydophila pneumoniae
- Haemophilus influenzae
- Klebsiella pneumoniae
- Legionella pneumophila
- Moraxella catarrhalis
- Morbillivirus Measles
- Parechovirus
- Varicella zoster virus (HHV3)
- Fungal Pathogens
- Pneumocystis jirovecii
- Viral Pathogens
- Cytomegalovirus (HHV5)
- Enterovirus 068
- Epidemic Parotitis (Mumps)
- Epstein-Barr virus (HHV4)
- Human Bocavirus (HBoV)
- Human Herpesvirus (HHV6)
- Human Metapneumovirus
- MERS-CoV
- Mycoplasma pneumonia
- Staphylococcus aureus
- Streptococcus pneumoniae
Many STIs go undetected without having significant symptoms. Our method identifies co-infections rapidly and accurately.
- Chlamydia trachomatis
- Gardnerella vaginalis
- Haemophilus ducreyi
- Herpes simplex 1
- Herpes simplex 2
- Mycoplasma genitalium
- Mycoplasma hominis
- Neisseria gonorrhoeae
- Treponema pallidum
- Trichomonas vaginalis
- Ureaplasma urealyticum
Luxor Scientific’s UTI testing panel overcomes limitations of traditional culture techniques and can provide accurate identification of polymicrobial infections.
- Candida glabrata
- Candida parapsilosis
- Candida tropicalis
- Enterobacter cloacae
- Enterococcus faecalis
- Escherichia coli
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Mycoplasma hominis
- Proteus mirabilis
- Providencia stuartii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Staphylococcus saprophyticus
- Streptococcus agalactiae (GBS)
- Ureaplasma urealyticum
This allows for identification of co-infections and pathogens that do not routinely grow well using culture.
- Acinetobacter baumannii
- Bacteroides spp.
- Citrobacter freundii & braakii
- Enterobacter aerogenes
- Enterobacter cloacae
- Enterococcus faecalis
- Enterococcus faecium
- Escherichia coli
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Proteus mirabilis
- Proteus vulgaris
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Streptococcus pyogenes
Correct knowledge of the infectious agents provides guidance for optimal treatment and minimizes possible toxic medication side effects.
- Candida albicans
- Candida glabrata
- Candida krusei
- Candida tropicalis
- Trichophyton anthropophilic spp.
- Trichophyton zoophilic spp.
- Alternaria spp.
- Aspergillus spp.
- Candida parapsilosis
- Cryptococcus spp.
- Curvularia
- Epidermophyton
- Fusarium spp.
- Malassezia spp.
- Meyerozyma guilliermondii
- Microsporum canis
- Sarocladium strictum
- Scytalidium dimidiatum
- Trichosporon
With emergence of new and more resistant bacterial and viral pathogens, it remains important and relevant for laboratories to stay up to date with sensitive and specific methods of detection. Luxor can provide monkey pox testing in our Laboratory, as the CDC data shows a recent uptick in positive cases were observed in January 2023, especially in our local region and neighboring states.
- Orthopoxvirus
- Monkeypox Virus
Knowing what drugs are most likely to treat the specific infection is increasingly important to help guide antibiotic treatment and allow appropriate relief for a patient.
- Temoniera-β-lactamase (TEM)
- Sulfhydryl Variable-β-lactamase (SHV)
- Klebsiella pneumoniae carbapenemase (KPC)
- CefoTaXime-M-β-lactamase (CTXM 1)
- CefoTaXime-M-β-lactamase (CTXM 2)
- CefoTaXime-M-β-lactamase (CTXM 8)
- CefoTaXime-M-β-lactamase (CTXM 9)
- CefoTaXime-M-β-lactamase (CTXM 25)
- New Delhi metallo-β-lactamase (NDM)
- Verona integron-encoded metallo-β-lactamase (VIM)
- Verona integron-encoded metallo-β-lactamase (VIM 7)
- Verona integron-encoded metallo-β-lactamase (VIM 13)
- Cephamycinase (CMY 1)
- Cephamycinase (CMY 2)
- Cefoxitin-Hydrolyzing Class C-β-lactamase (FOX)
- Oxacillinase Group (OXA 1)
- Oxacillinase Group (OXA 2)
- Oxacillinase Group (OXA 48)
- Methicillin Resistence (mecA)
- Sulfonamide-Resistant isolate (Sul 1)
- Sulfonamide-Resistant isolate (Sul 2)
- Sulfonamide-Resistant isolate (Sul 3)
- Erythromycin Resistance Gene (ermB)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrA 1)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrB 1)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrB 5)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrS)
- Vancomycin Resistance (Van A)
- Vancomycin Resistance (Van B)
- Vancomycin Resistance (VanC 1)
- Vancomycin Resistance (VanC 2-4)
- Tracking and reporting of microbes and resistance genes
- Important microbiology infection rates and percentages
- Drug expertise and dosage recommendations
- Plans of action, protocols, and guidelines
- Infection control measures
- Continuing education
With this increase, there has been an increase in tick-borne illnesses, such as Rocky Mountain Spotted Fever (RMSF) and Lyme disease (Lyme borreliosis), that are directly linked with tick bites. At Luxor, our infectious disease serology laboratory offers specialized and rapid testing for detection of RMSF and Lyme Disease to detect antibody response to these organisms, by showing either seroconversion from antibody negative to antibody positive, or by documenting a significant increase in IgG antibody titers. These serologic tests are not widely available, yet we offer 48-hour turn-around time offered by our laboratory for this testing.
- Rickettsia rickettsii (Rocky Mountain Spotted Fever) Antibody, IgG
- Rickettsia rickettsii (Rocky Mountain Spotted Fever) Antibody, IgM
- Borrelia burgdorferi Antibodies, Total
Molecular results, including antibiotic resistance, can provide clinicians with the information needed to prescribe the right treatment plan the first time.